Accidental intra-arterial injection of 2 to 8 ml propofol has been reported. 13 On two occasions there were no complications other than pain,2.3 and in the third, propofol caused local blanching in an oval area within five seconds and a hyperaemic appearance thirty minutes later. 1 We would like to report the inadvertent injection of 10 ml propofol into the left brachial artery in which there was a transient decrease in blood flow to the distal limb.
CASE REPORT
A 72-year-old, 45 kg woman was scheduled for a rectus ab dominus flap for a pressure sore. She had poor venous access and after multiple attempts a 24-gauge cannula (Jelco) was inserted into the left antecubital fossa. Blood was seen to be slowly dripping back from the cannula, but it was not considered to be arterial. A pulse oximeter was placed on the left index finger and fentanyl 50 mcg was given uneventfully followed ten seconds later by propofol 3 ml at room temperature (lO ml drawn up). The patient immediately complained of severe local pain which lasted thirty seconds. A small hyperaemic area was noted around the cannula, but the patient denied radiation of the pain into the arm. Furthermore, circulation to the distal arm appeared normal with no change in the SpOz or pulse volume. Backflow from the cannula remained slow. Presuming that the pain was venous in origin, I mllignocaine 2070 was added to the syringe and a further 8 ml of propofol injected 1.5 minutes after completion of the first dose. The patient again complained of severe local pain, but this time radiating to the hand, before becoming drowsy a few seconds later. In addition, the area of hyperaemia area around the cannula site became more noticeable (lO x 6 cm), and the distal arm took on a grey-blue appearance. SpOz in the index finger fell to 85% and with poor pulse volume. In contrast throughout this period the right arm remained pink (SpOz 99%), perfused and with good pulse volume. There was no evidence of systemic disturbance. At this point it was noted that the remaining propofol in the syringe was stained bright red. When anaesthesia was established, the cannula was removed and a local haematoma developed. The circulation to the distal arm gradually returned after five minutes and there were no postoperative sequelae.
DISCUSSION
Although blood gas analysis was not performed, intra-arterial placement of the cannula seems likely. This case highlights the dangers of using a 24-gauge cannula in the antecubital fossa where displacement can readily occur and intra-arterial injection is less easily detected. We could find no data on the intraarterial injection of fentanyl, but the timing of events is strongly suggestive of propofol as the cause of the pain and decreased blood flow. When given intravenously, pain from propofol is directly related to its free aqueous concentration 4 and following intra-arterial injection the concentration is likely to remain very high. It is interesting to note that the pain did not radiate distally following the test dose and was not eliminated by the addition of lignocaine. We would suggest that severe pain on injection of propofolllignocaine mixture into the antecubital fossa indicates intra-arterial injection until proven otherwise.
Case reports and laboratory studies have indicated the benign nature of intra-arterial propofol.l3 Studies on the isolated rabbit ear artery have demonstrated that propofol does not affect the vasoactivity or myogenic properties of smooth muscle and does not alter endothelial or smooth muscle histology. 5 This is in marked contrast to thiopentone which causes an intense chemical arteritis throughout the vessel wall resulting in severe ischaemia in a similar animal preparation. 6 Intra-arterial injection of thiopentone requires urgent management which may include intra-arterial lignocaine or papaverine, stellate ganglion or brachial plexus blockade, and anticoagulation.
In only one report has there been evidence of any haemodynamic disturbance' following accidental intraarterial injection of propofol. This current case demonstrates that large doses can lead to a transient reduction of blood flow, but that limb morbidity remains unlikely and that specific management is probably not required.
